跳到正文
TechCrunch AI· Ram Iyer·· 5 天前AI 评分70

Isomorphic Labs 完成50亿美元C轮融资以推进候选药物进入临床试验

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

AI 导读

从Google DeepMind拆分出的AI药物研发平台Isomorphic Labs完成50亿美元C轮融资,由Greenoaks和红杉资本联合领投,资金将用于持续开发AI药物设计引擎并将候选药物推向临床试验。该平台基于AlphaFold技术构建,目前已在肿瘤学和免疫学领域取得积极的临床前结果,并已与礼来、诺华和强生等制药巨头达成合作。

正文 · 原文

In Brief

Posted:

6:50 AM PST · November 17, 2026

Demis Hassabis, chief executive officer of DeepMind Technologies
Image Credits:Jose Sarmento Matos/Bloomberg / Getty Images
  • Ram Iyer

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round as it seeks to take its drug candidates to clinical trials.

The funding was co-led by Greenoaks and Sequoia Capital, with new investor Andreessen Horowitz and other investors also participating. All of the company’s existing backers, including Alphabet’s venture divisions GV and Capital G, Thrive Capital, MGX, Temasek, and the UK Sovereign AI Fund, also invested.

Isomorphic Labs builds an AI drug-design engine that uses a slew of simulation AI models that explore various areas of chemistry to help the company design drugs. The company, whose work builds on DeepMind’s breakthrough AlphaFold protein-folding AI model, said its program has yielded “positive preclinical results” in oncology and immunology. The lab has struck deals with pharma giants like Eli Lilly, Novartis, and Johnson & Johnson.

The new funding, which comes on the heels of a $2.1 billion Series B round in May, will be used to continue developing its drug-design engine, as well as to foray into more types of medicine.

The Series C is Isomorphic’s first fundraise since its founder and CEO, Demis Hassabis, left his position as head of DeepMind to focus on drug discovery, which also saw him moving into a chairman role at DeepMind. Hassabis and then-director of DeepMind John Jumper won the Nobel Prize in chemistry for the lab’s work on AlphaFold, a system that predicts the 3D structure of proteins with nothing more than their genetic sequence.

Isomorphic did not disclose its new valuation. Bloomberg reported earlier this month that the lab was looking to raise funding at a $50 billion valuation.

来源:TechCrunch AI · techcrunch.com

EVAOO 主站实战落地 · 大模型与 AI 内容工程

看完情报?回到 EVAOO 主站直接上手工具与完整 SOP

返回 EVAOO 主站